A Study to Investigate the Ability of GSK706769 to Maintain Clinical Remission After Withdrawal of Enbrel in Rheumatoid Arthritis Patients

NCT00979771 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Cancelled Before Active

Conditions

Arthritis, Rheumatoid

Interventions

DRUG: GSK706769
DRUG: Placebo

Sponsor

GlaxoSmithKline